Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-02

Clinical Trial Update: Clavulanic Acid for the Treatment of Cocaine Use Disorder [Phase 2]

View source ↗

Summary

This document updates the status of a Phase 2 trial evaluating clavulanic acid for cocaine dependence, noting the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clavulanic Acid (clavulanic acid)

Snippet

Sponsor: Temple University | Conditions: Cocaine Dependence | Phase 2 | Status: ACTIVE_NOT_RECRUITING